Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1567 studies found for:    "Acute lymphoblastic leukemia"
Show Display Options
Rank Status Study
21 Completed Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL)
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: imatinib;   Drug: cyclophosphamide;   Drug: daunorubicin;   Drug: vincristine;   Drug: prednisolone;   Drug: methotrexate;   Drug: cytarabine;   Drug: dexamethasone
22 Active, not recruiting A Study in Adults With Untreated Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: prednisone;   Drug: doxorubicin;   Drug: vincristine;   Drug: methotrexate;   Drug: asparaginase;   Drug: dexamethasone;   Radiation: cranial radiation;   Drug: leucovorin;   Drug: cytarabine;   Drug: hydrocortisone;   Drug: 6-mercaptopurine (6-MP);   Drug: e. coli L-asparaginase
23 Terminated CD19-CAR Immunotherapy for Childhood Acute Lymphoblastic Leukemia (ALL)
Condition: Acute Lymphoblastic Leukemia
Interventions: Genetic: donor-derived EBV-specific cytotoxic T-cells (EBV-CTL) transduced with the retroviral vector SFGalpha-CD19-CD3zeta;   Biological: Irradiated donor-derived Lymphoblastoid Cell Line
24 Completed Neurologic Morbidity and Disability in Acute Lymphoblastic Leukemia Survivors
Condition: Acute Lymphoblastic Leukemia
Intervention: Other: Neurological Examination/Questionnaires
25 Completed The Influence of Thiopurine Methyltransferase Activity on Toxicity After High-dose Methotrexate in Childhood Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Intervention:
26 Recruiting Treatment for Executive Dysfunction in Adult Survivors of Childhood Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Device: transcranial Direct Current Stimulation (tDCS);   Device: Sham;   Other: Cognitive Assessment;   Other: Brain Games Stimulation
27 Completed Rapamycin in Relapsed Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: Corticosteroid;   Drug: Rapamycin
28 Terminated Treatment of Childhood Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: asparaginase (E. Coli);   Drug: asparaginase (Erwina);   Drug: dexrazoxane;   Drug: doxorubicin;   Procedure: cranial radiation (once daily fractionation);   Procedure: cranial radiation (twice-daily fractionation);   Procedure: Intrathecal chemotherapy without radiation
29 Unknown  Phase III Study of Vincristine Sulfate Liposome For Injection In Adults With Naïve Acute Lymphoblastic Leukemia
Condition: Adult Acute Lymphoblastic Leukemia
Interventions: Drug: Vincristine Sulfate Liposome;   Drug: Vincristine Sulfate
30 Completed STI 571 (GLIVEC) in the Treatment of Adult Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Intervention: Drug: Imatinib
31 Completed Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL)
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: bortezomib (Velcade);   Drug: dexamethasone;   Drug: PEG-asparaginase;   Drug: doxorubicin;   Drug: cytarabine;   Drug: methotrexate;   Drug: vincristine
32 Recruiting Blinatumomab Maintenance Following Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: Blinatumomab;   Procedure: Hematopoietic Cell Transplantation
33 Active, not recruiting CMC-544 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: CMC-544 (Inotuzumab Ozogamycin);   Drug: Rituximab
34 Completed A Phase II, Open-Label Study of Clofarabine in Paediatric Patients With Refractory/Relapsed Acute Lymphoblastic Leukaemia
Condition: Acute Lymphoblastic Leukemia
Intervention: Drug: clofarabine
35 Suspended Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL)
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: Liposomal cytarabine;   Drug: Intrathecal triple
36 Completed Feasibility of Risk-Adapted Therapy in Young Adult Acute Lymphoblastic Leukemia: a Multicenter Trial
Condition: Acute Lymphoblastic Leukemia
Intervention: Procedure: Collection of treatment-stratefying prognostic factors
37 Completed ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia Intermittent Versus Continuous PEG Asparaginase
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: PEG Asparaginase at six weeks interval;   Drug: PEG Asparaginase at two weeks interval
38 Completed
Has Results
Treatment of Older Adults With Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: Prednisone;   Drug: Vincristine;   Drug: Doxorubicin;   Drug: PEG-asparaginase;   Drug: Cytarabine;   Drug: Methotrexate;   Drug: Imatinib;   Drug: Clofarabine;   Drug: 6 Mercaptopurine
39 Withdrawn Cardiometabolic Status in Childhood Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Intervention:
40 Active, not recruiting Clofarabine-cyclophosphamide as Salvage Therapy for Refractory and Relapsed Acute Lymphoblastic Leukemia (ALL) Adults
Condition: Acute Lymphoblastic Leukemia
Intervention: Drug: Clofarabine, Cyclophosphamide

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.